HAE
Haemonetics Corporation
NYSE · Healthcare · Medical - Instruments & Supplies · US
$102.92
+0.07%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+44.3%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 28, 2026 | Madaus Martin D · director | A-Award | 2,538 | $0.00 |
| Jul 28, 2026 | COYLE MICHAEL J · director | A-Award | 2,538 | $0.00 |
| Jul 28, 2026 | Pomeroy Claire · director | A-Award | 2,538 | $0.00 |
| Jul 28, 2026 | Bryant Diane M · director | A-Award | 2,538 | $0.00 |
| Jul 28, 2026 | Johnson Lloyd Emerson · director | A-Award | 2,538 | $0.00 |
| Jul 28, 2026 | Zane Ellen M · director | A-Award | 2,538 | $0.00 |
| Jul 28, 2026 | KROLL MARK W · director | A-Award | 2,538 | $0.00 |
| Jul 28, 2026 | ABERNATHY ROBERT E · director | A-Award | 2,538 | $0.00 |
| Jun 8, 2026 | Miller Laurie A. · officer: SVP, Human Resources | F-InKind | 313 | $71 |
| Jun 8, 2026 | Maunsell Farris Maryanne · officer: VP, Chief Accounting Officer | F-InKind | 259 | $71 |
| May 19, 2026 | Simon, Christopher · director, officer: President & CEO | F-InKind | 9,681 | $56 |
| May 19, 2026 | Chan Frank · officer: EVP, Chief Operating Officer | F-InKind | 546 | $56 |
| May 19, 2026 | Miller Laurie A. · officer: SVP, Human Resources | A-Award | 13,323 | $0.00 |
| May 19, 2026 | Simon, Christopher · director, officer: President & CEO | A-Award | 78,344 | $0.00 |
| May 19, 2026 | Basil Michelle L · officer: EVP and General Counsel | F-InKind | 2,913 | $56 |
| May 19, 2026 | Basil Michelle L · officer: EVP and General Counsel | A-Award | 28,424 | $0.00 |
| May 19, 2026 | DArecca James · officer: EVP, Chief Financial Officer | F-InKind | 2,505 | $56 |
| May 19, 2026 | DArecca James · officer: EVP, Chief Financial Officer | A-Award | 29,312 | $0.00 |
| May 19, 2026 | Miller Laurie A. · officer: SVP, Human Resources | F-InKind | 948 | $56 |
| May 19, 2026 | Maunsell Farris Maryanne · officer: VP, Chief Accounting Officer | F-InKind | 197 | $56 |
| May 19, 2026 | Galvin Roy · officer: EVP, Chief Commercial Officer | A-Award | 27,535 | $0.00 |
| May 19, 2026 | Maunsell Farris Maryanne · officer: VP, Chief Accounting Officer | A-Award | 2,220 | $0.00 |
| May 19, 2026 | Galvin Roy · officer: EVP, Chief Commercial Officer | F-InKind | 879 | $56 |
| May 19, 2026 | Chan Frank · officer: EVP, Chief Operating Officer | A-Award | 27,535 | $0.00 |
| May 5, 2026 | DArecca James · officer: EVP, Chief Financial Officer | F-InKind | 655 | $59 |
| Nov 12, 2025 | KROLL MARK W · director | Purchase | 1,400 | $71 |
| Nov 3, 2025 | Galvin Roy · officer: EVP, Chief Commercial Officer | F-InKind | 145 | $50 |
| Sep 24, 2025 | Miller Laurie A. · officer: SVP, Human Resources | F-InKind | 238 | $50 |
| Jul 25, 2025 | Zane Ellen M · director | A-Award | 2,693 | $0.00 |
| Jul 25, 2025 | Pomeroy Claire · director | A-Award | 2,693 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 112Increased 228Reduced 237Sold out 47
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 5,909,258 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 5,619,979 | May 13, 2026 |
| Neuberger Berman Group LLC | Increased | 4,179,443 | Aug 13, 2026 |
| NEUBERGER BERMAN GROUP LLC | Reduced | 3,560,918 | May 14, 2026 |
| AQR CAPITAL MANAGEMENT LLC | Increased | 3,356,543 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 2,559,316 | May 8, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Reduced | 2,546,394 | Aug 13, 2026 |
| AQR CAPITAL MANAGEMENT LLC | Reduced | 2,266,489 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,090,389 | May 15, 2026 |
| ARIEL INVESTMENTS, LLC | New Position | 2,060,966 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 2,059,578 | Aug 13, 2026 |
| STATE STREET CORP | Increased | 1,818,186 | Aug 7, 2026 |
| STATE STREET CORP | Increased | 1,772,898 | May 15, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Increased | 1,585,222 | Aug 11, 2026 |
| CITADEL ADVISORS LLC | Increased | 1,540,320 | Sep 2, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 28, 2026